Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

By E. Batrakova, A. Kabanov. Journal of Controlled Release, 2008

1,221 citations recorded by the source corpus.

Subfields: Biomaterials, Oncology, Polymers and Plastics

View Paper: https://www.semanticscholar.org/paper/816218fde7600004f73b81248c1c74a529f6fc64

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. R. Gabathuler

In Oncology

1. R. Gabathuler

In Polymers and Plastics

1. R. Gabathuler

Citations in the corpus

• Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. (2010, background): “…of drugs facilitates brain delivery by increasing the drug solubility and stability in plasma Incorporation of low molecular mass drugs into pluronic micelles can increase drug solubility and drug stability, and can improve drug pharmacokinetics and biodistribution (Batrakova and Kabanov, 2008).”
• High drug-loading nanomedicines: progress, current status, and prospects (2017, neutral): “217 For most of the high drug-loading nanomedicines, it is hard to realize in vivo controlled release, such as ultrasound-controlled release, magnetism-controlled release, and microwave-controlled release.”